Aptive Capital invests in early-stage technology startups and founders.
We invest in founders who are passionate about challenging the status quo and effecting positive change.
The Aptive Capital portfolio is primarily made up of market-validated startups from our corporate-backed innovation programmes, with a focus on FinTech, HealthTech and Smart Cities.
We employ a hands-on approach in working with our portfolio companies, whether it be for fundraising support, client acquisition, industry expertise through our network of mentors or general business and advisory.
Leveraging our established strategic partnerships with multinationals and government entities, we have the ability to influence and shorten the sales cycle for B2B and B2B2C startups, helping companies from around the world pursue commercial growth in The United States, Africa and globally.
Aptive Capital in short
Stage: Seed & Series A.
Range: $5k to $1M.
Industries: FinTech, HealthTech, E-Commerce, Agribusiness and Smart Cities.
Geographies: Global, but with an active presence in The United States and Africa.